Urgent warning over new £30 ‘Ozempic-like’ weight loss PILLS that are ‘better than Mounjaro’ – as ‘fakes’ flood TikTok
FAKE Ozempic-style pills are being sold online for rock-bottom prices as crooks try to cash in on the slimming jab craze. Dieters have been warned not to fall for dangerous scams as it is impossible to know what is in the drugs. SUPPLIED Pharmacists say people are buying ‘G1P-1 powder’ from TikTok[/caption] WOLVERINE PEPTIDESWolverine Peptides […]
Eccogene files for Hong Kong IPO to back development of GLP-1 pipeline
Eccogene, a clinical-stage biotech whose oral GLP-1 drug forms the backbone of AstraZeneca’s obesity pipeline, is planning an initial public offering on the Hong Kong Stock Exchange. The biotech made public a 550-page
Bridget Fonda, 61, looks thinner than ever as expert weighs in on how the ’90s star lost 75lbs
‘Fonda could have taken the diabetes drug Ozempic that could have aided in her weight loss journey or she could have tried GLP-1 agonists like semaglutide and a tirzepatide.’
Huel Lite range caters to calorie-conscious and snack-seekers
Huel has introduced the ‘Lite’ range, featuring low-calorie, high-protein ready-to-drink meals aimed at calorie-conscious consumers and snack-seekers. With 25 grams of protein and just 190 calories per 500 ml bottle, the drinks come in chocolate, banana and strawberry flavors, promoting muscle strength, gut health, and energy. The launch addresses consumer demand for nutrient-dense, everyday wellness […]
More Patients Using GLP-1 Drugs Prior To Weight-Loss Surgery
By Dennis Thompson HealthDay ReporterWEDNESDAY, Oct. 8, 2025 (HealthDay News) — Many more folks fighting excess weight are using weight-loss drugs…
Initiating GLP-1 Drugs May Slightly Raise Depression Risk
Patients with T2D and overweight/obesity starting GLP-1 therapy may experience a small but statistically significant increase in the risk for depression compared with those starting SGLT2 inhibitors. Medscape Medical News
Dr Megan Rossi and Gemma Ogston on how to heal your gut and eat 30 plants a week
Gut health is one of the biggest trends of the year. It’s a catch-all term that’s been used to sell supplements, spook people about their diets and encourage disordered eating. But it’s also prompted a spike in sales of gut-friendly foods, an uptick in body literacy and an arguably healthier population. Leading gut health expert […]
Relative efficacy of GLP‐1 and GLP‐1/GIP receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach
Abstract Aims There is growing evidence that the GLP-1 system is implicated in alcohol and other substance use disorders, and that GLP-1-based therapies may have therapeutic relevance in alcohol use disorder (AUD). We aimed to determine the impact of GLP-1 based therapies on incident AUDs in a real-world setting in patients with T2D. Material and […]
Gut Delivery of Pentameric GLP-1 Using Genetically Engineered Bacillus subtilis for Diabetes and Obesity Treatment
Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and {beta}-cell dysfunction. Glucagon-like peptide-1 (GLP-1) has emerged as a pivotal therapeutic target due to its roles in promoting insulin secretion, regulating appetite, and enhancing lipid metabolism. However, GLP-1-based therapies face significant challenges, including high production costs, complex delivery methods, and […]
New ‘unusual’ side effect of weight-loss drugs becoming more common, research suggests
GLP-1 drugs may interfere with medical imaging, leading to unnecessary tests, researchers have found